Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 13 04:00PM ET
24.47
Dollar change
-0.23
Percentage change
-0.93
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y- Shs Outstand Perf Week1.83%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- Total Holdings32 Perf Month3.91%
Fund Family Bond Type Tagsinnovation Return% 5Y- AUM54.79M Perf Quarter1.36%
Index- Average Maturity Tagshealthcare Return% 10Y NAV% Perf Half Y-3.80%
Index Weighting Commodity Type Tagsbiotechnology Return% SI NAV/sh Perf Year-
Active/Passive Quant Type Tagsmedical Flows% 1M0.02% 52W Range18.78 - 27.76 Perf YTD4.61%
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M1.96% 52W High-11.85% Beta-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD7.38% 52W Low30.30% ATR (14)0.44
Expense0.54% Structure Type Region Flows% 1Y RSI (14)61.58 Volatility1.51% 2.01%
Option/ShortNo / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.01 Prev Close24.70
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume3.15K Price24.47
SMA204.62% SMA508.21% SMA2001.39% Trades Volume22 Change-0.93%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.